aTyr Pharma/$ATYR.
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About aTyr Pharma
aTyr Pharma Inc is a clinical-stage biotechnology company focused on developing therapies for fibrosis and inflammatory conditions. Its research leverages tRNA synthetase biology to identify potential therapeutic targets. The company's discovery platform uses a proprietary library of domains derived from tRNA synthetases to explore signaling pathways. Its flagship clinical candidate, efzofitimod, is a novel biologic immunomodulatory in development for the treatment of interstitial lung disease (ILD).
- Ticker
- $ATYR.
- Sector
- Health
- Primary listing
- NASDAQ
- Employees
- 59
- Headquarters
- San Diego, United States
- Website
- atyrpharma.com
aTyr Pharma Metrics
BasicAdvanced
$17M
-
-$21.74
-
-
Price and volume
Market cap
$17M
52-week high
$7.98
52-week low
$0.10
Average daily volume
1.4M
Financial strength
Current ratio
3.152
Quick ratio
3.088
Long term debt to equity
0.283
Total debt to equity
0.323
Profitability
EBITDA (TTM)
-55.235
Management effectiveness
Return on assets (TTM)
-41.98%
Return on equity (TTM)
-93.68%
Valuation
Price to book
0.49
Price to tangible book (TTM)
0.49
Growth
Revenue change (TTM)
-100.00%
Earnings per share change (TTM)
-35.49%
3-year earnings per share growth (CAGR)
-16.60%
10-year earnings per share growth (CAGR)
-34.35%
What the Analysts think about aTyr Pharma
Analyst ratings (Buy, Hold, Sell) for aTyr Pharma stock.
Analyst projections of the future price of aTyr Pharma stock.
aTyr Pharma Financial Performance
Revenues and expenses
aTyr Pharma Earnings Performance
Company profitability
Upcoming events
No upcoming events
aTyr Pharma News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.